Leptin Induces Upregulation of Sphingosine Kinase 1 in Oestrogen Receptor-negative Breast Cancer Via Src Family Kinase-mediated, Janus Kinase 2-independent Pathway
Overview
Authors
Affiliations
Introduction: Obesity is a known risk factor for breast cancer. Sphingosine kinase 1 (SK1) is an oncogenic lipid kinase that is overexpressed in breast tumours and linked with poor prognosis, however, its role in obesity-driven breast cancer was never elucidated.
Methods: Human primary and secondary breast cancer tissues were analysed for SK1 and leptin receptor expression using quantitative real-time polymerase chain reaction (qRT-PCR) assay. Leptin-induced signalling was analysed in human oestrogen receptor (ER)-positive and negative breast cancer cells using Western blotting, qRT-PCR and radiolabelling assays.
Results: Our findings show for the first time that human primary breast tumours and associated lymph node metastases exhibit a strong correlation between SK1 and leptin receptor expression (Pearson R = 0.78 and R = 0.77, respectively, P <0.001). Both these genes are elevated in metastases of ER-negative patients and show a significant increase in patients with higher body mass index (BMI). Leptin induces SK1 expression and activation in ER-negative breast cancer cell lines MDAMB-231 and BT-549, but not in ER-positive cell lines. Pharmacological inhibition and gene knockdown showed that leptin-induced SK1 activity and expression are mediated by activation of extracellular signal-regulated kinases 1/2 (ERK1/2) and Src family kinase (SFK) pathways, but not by the major pathways downstream of leptin receptor (LEPR) - janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3). Src-homology 2 domain-containing phosphatase 2 (SHP2) appeared to be key to SK1 activation, and may function as an adaptor protein between SFKs and LEPR. Importantly, leptin-induced breast cancer cell proliferation was abrogated by SK1-specific small interfering RNA (siRNA).
Conclusions: Overall, our findings demonstrate a novel SFK/ERK1/2-mediated pathway that links leptin signalling and expression of oncogenic enzyme SK1 in breast tumours and suggest the potential significance of this pathway in ER-negative breast cancer.
Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.
PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.
Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study.
Nguyen Q, Nguyen P, Wang C, Phuc P, Lin R, Hung C Cancer Sci. 2023; 114(10):4063-4072.
PMID: 37489252 PMC: 10551582. DOI: 10.1111/cas.15917.
The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems.
Misch M, Puthanveetil P Int J Mol Sci. 2022; 23(10).
PMID: 35628271 PMC: 9141226. DOI: 10.3390/ijms23105439.
Hii L, Chung F, Mai C, Ng P, Leong C Front Mol Biosci. 2021; 8:748470.
PMID: 34820423 PMC: 8606534. DOI: 10.3389/fmolb.2021.748470.
Umar M, Hassan W, Murtaza G, Buabeid M, Arafa E, Irfan H Pathol Oncol Res. 2021; 27:1609828.
PMID: 34588926 PMC: 8473628. DOI: 10.3389/pore.2021.1609828.